As we found considerable impact of GLI1 and GLI3 gene expression on patient survival, this study demonstrates that inhibition of Hh signaling may be a promising drug target for the treatment of advanced lung adenocarcinoma. This evidence concerns the gene GLI1 and lung adenocarcinoma.